Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • SOP Guidelines
    • SOP Development
    • SOP Training
    • SOP Compliance Monitoring
    • SOP Revision Processes
    • Pharmaceutical SOP templates
    • GMP documentation SOP
    • Data integrity SOP pharma
    • Manufacturing SOP pharmaceutical
    • FDA SOP guidance
    • eQMS SOP workflows
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • GMP Audit Findings
    • Non-Compliance
      • SOP Absence
      • Revision Control
      • Non-Adherence
      • Poor Writing
      • Training Failure
      • Data Integrity Gaps
      • Mismatch Between SOPs and Practice
      • Critical Operations
      • Regulatory Change
      • Emergency Changes
      • Third-Party SOPs
      • Inspection Readiness
      • Deviation Handling
      • CAPA Integration
      • Validation Alignment
      • System Integration
      • Uncontrolled Distribution
      • SOP Implementation Gaps
      • SOP Alignment with Validation
      • Change Control Linkage
  • Toggle search form

API Manufacturing: SOP for Management Review of Quality Metrics – V 2.0

Posted on By

API Manufacturing: SOP for Management Review of Quality Metrics – V 2.0

Standard Operating Procedure for Management Review of Quality Metrics in API Manufacturing

Department API Manufacturing
SOP No. SOP/API/168/2025
Supersedes SOP/API/168/2022
Page No. Page 1 of 13
Issue Date 14/04/2025
Effective Date 16/04/2025
Review Date 14/04/2026

1. Purpose

To define the procedure for conducting periodic Management Reviews of quality metrics within the API manufacturing facility. This ensures the adequacy, suitability, and effectiveness of the Quality Management System (QMS) and promotes continuous improvement.

2. Scope

This SOP is applicable to the Quality Assurance (QA) department and other cross-functional departments involved in providing data for Quality Metrics

and participating in Management Review Meetings (MRMs) for the API manufacturing site.

3. Responsibilities

  • QA Head: Coordinates the management review process, compiles data, presents findings, and tracks action items.
  • Department Heads: Provide necessary input data related to deviations, complaints, change controls, OOS, CAPA, etc.
  • Site Head / Plant Head: Chairs the meeting and ensures strategic decisions are taken based on data.
  • Management Review Committee: Reviews metrics and makes decisions on improvements and resource needs.
See also  API Manufacturing: SOP for Monitoring Warehouse Temperature and Humidity - V 2.0

4. Accountability

The QA Head is accountable for organizing, documenting, and ensuring follow-up of action items from management reviews in compliance with GMP and ICH Q10 requirements.

5. Procedure

5.1 Frequency of Management Reviews

  1. Management Review Meetings shall be conducted quarterly (every three months).
  2. Additional meetings may be scheduled in response to significant events like product recalls, regulatory inspections, or critical deviations.

5.2 Formation of Management Review Committee

  1. The committee shall comprise representatives from:
    • Quality Assurance (Chairperson)
    • Production
    • Quality Control
    • Warehouse
    • Regulatory Affairs
    • Engineering and Maintenance
    • Site Head / Plant Head
  2. QA shall maintain a list of current committee members and ensure quorum during meetings.

5.3 Preparation for Management Review Meeting

  1. QA shall compile Quality Metrics from various departments for the previous quarter using the format in Annexure-1.
  2. The review shall include but not be limited to:
    • Deviations, CAPA, and OOS trends
    • Audit findings (internal and external)
    • Change controls opened and closed
    • Product quality complaints
    • Market recalls (if any)
    • Training compliance
    • Yield trends and batch failure rates
    • Status of regulatory commitments
    • Environmental monitoring and equipment calibration trends
  3. QA shall prepare the meeting agenda (Annexure-2) and circulate it 5 days before the scheduled meeting.

5.4 Conducting the Management Review Meeting

  1. The Site Head or designee shall chair the meeting and QA shall serve as the secretary.
  2. Each agenda point shall be discussed with presentation of metrics, graphs, and action trackers.
  3. Discussion outcomes shall be recorded in the Management Review Minutes (Annexure-3).
  4. Decisions shall be made regarding:
    • Quality system improvement needs
    • Additional training or resources
    • Amendments to procedures
    • Corrective actions for repeated failures or observations
See also  API Manufacturing: SOP for Calibration and Maintenance of pH Meter - V 2.0

5.5 Post-Meeting Actions

  1. QA shall prepare and circulate signed meeting minutes within 7 working days.
  2. Action items identified shall be tracked through the Management Review Action Tracker (Annexure-4).
  3. Each department shall submit implementation status of assigned actions to QA within the defined target dates.
  4. QA shall verify and close the action items after review.

5.6 Trending and Summary Reports

  1. QA shall perform quarterly and annual trending of:
    • CAPA closure timelines
    • Recurring deviations and complaints
    • Revalidation or requalification triggers
  2. A consolidated yearly summary of quality metrics and actions shall be prepared and shared with top management.

6. Abbreviations

  • QA: Quality Assurance
  • CAPA: Corrective and Preventive Action
  • OOS: Out of Specification
  • MRM: Management Review Meeting
  • QMS: Quality Management System

7. Documents

  1. Quality Metrics Compilation Sheet (Annexure-1)
  2. Management Review Agenda Format (Annexure-2)
  3. Management Review Meeting Minutes (Annexure-3)
  4. Management Review Action Tracker (Annexure-4)
See also  API Manufacturing: SOP for Preparation and Storage of Working Standards - V 2.0

8. References

  • ICH Q10: Pharmaceutical Quality System
  • 21 CFR Part 211 – GMP for Finished Pharmaceuticals
  • EU GMP – Chapter 1: Pharmaceutical Quality System

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name
Designation
Department

11. Annexures

Annexure-1: Quality Metrics Compilation Sheet

Parameter Q1 Q2 Q3 Q4
Deviations 12 9 15 11
OOS Results 3 2 4 1
Complaints 1 0 1 0

Annexure-2: Management Review Agenda Format

Agenda Item Description Presenter
1 Review of Previous Actions QA
2 Quality Metrics Trends QA
3 Audit and Compliance Status Regulatory

Annexure-3: Management Review Meeting Minutes

Meeting Date Chairperson Attendees Summary
10/04/2025 Site Head QA, QC, Production, RA Discussed deviation trends and proposed CAPA automation

Annexure-4: Management Review Action Tracker

Action Item Department Target Date Status Closure Date
Revise deviation form to include RCA checklist QA 25/04/2025 Open —

Revision History:

Revision Date Revision No. Details Reason Approved By
01/01/2022 1.0 Initial SOP Release Implementation QA Head
14/04/2025 2.0 Expanded annexures, added frequency and review structure GMP Compliance QA Head
API Manufacturing V 2.0 Tags:API batch record, API BMR, API calibration, API centrifuge, API cleaning, API crystallization, API deviation, API documentation, API drying, API equipment cleaning, API filtration, API GMP compliance, API granulation, API hold time, API impurities, API line clearance, API manufacturing, API process, API quality control, API reactor, API sampling, API solvent handling, API validation, API waste disposal, API yield

Post navigation

Previous Post: Gel Manufacturing: SOP for Microbial Testing of Gels – V 2.0
Next Post: Analytical Method Development: Mass Spectral Fragmentation Analysis SOP – V 2.0

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Gels V 2.0
  • Injectables V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version